166 related articles for article (PubMed ID: 38229158)
21. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
[TBL] [Abstract][Full Text] [Related]
22. Methylation classifiers: Brain tumors, sarcomas, and what's next.
Koelsche C; von Deimling A
Genes Chromosomes Cancer; 2022 Jun; 61(6):346-355. PubMed ID: 35388566
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
24. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
Jaunmuktane Z; Capper D; Jones DTW; Schrimpf D; Sill M; Dutt M; Suraweera N; Pfister SM; von Deimling A; Brandner S
Acta Neuropathol Commun; 2019 Feb; 7(1):24. PubMed ID: 30786920
[TBL] [Abstract][Full Text] [Related]
25. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
[TBL] [Abstract][Full Text] [Related]
26. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.
Capper D; Stichel D; Sahm F; Jones DTW; Schrimpf D; Sill M; Schmid S; Hovestadt V; Reuss DE; Koelsche C; Reinhardt A; Wefers AK; Huang K; Sievers P; Ebrahimi A; Schöler A; Teichmann D; Koch A; Hänggi D; Unterberg A; Platten M; Wick W; Witt O; Milde T; Korshunov A; Pfister SM; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):181-210. PubMed ID: 29967940
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
28. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
[TBL] [Abstract][Full Text] [Related]
29. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR
J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472
[TBL] [Abstract][Full Text] [Related]
30. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
Sturm D; Capper D; Andreiuolo F; Gessi M; Kölsche C; Reinhardt A; Sievers P; Wefers AK; Ebrahimi A; Suwala AK; Gielen GH; Sill M; Schrimpf D; Stichel D; Hovestadt V; Daenekas B; Rode A; Hamelmann S; Previti C; Jäger N; Buchhalter I; Blattner-Johnson M; Jones BC; Warmuth-Metz M; Bison B; Grund K; Sutter C; Hirsch S; Dikow N; Hasselblatt M; Schüller U; Koch A; Gerber NU; White CL; Buntine MK; Kinross K; Algar EM; Hansford JR; Gottardo NG; Schuhmann MU; Thomale UW; Hernáiz Driever P; Gnekow A; Witt O; Müller HL; Calaminus G; Fleischhack G; Kordes U; Mynarek M; Rutkowski S; Frühwald MC; Kramm CM; von Deimling A; Pietsch T; Sahm F; Pfister SM; Jones DTW
Nat Med; 2023 Apr; 29(4):917-926. PubMed ID: 36928815
[TBL] [Abstract][Full Text] [Related]
31. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
32. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
[TBL] [Abstract][Full Text] [Related]
33. DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification.
Schmid K; Sehring J; Németh A; Harter PN; Weber KJ; Vengadeswaran A; Storf H; Seidemann C; Karki K; Fischer P; Dohmen H; Selignow C; von Deimling A; Grau S; Schröder U; Plate KH; Stein M; Uhl E; Acker T; Amsel D
Brain Pathol; 2024 May; 34(3):e13228. PubMed ID: 38012085
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
[TBL] [Abstract][Full Text] [Related]
35. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.
Deng MY; Sill M; Sturm D; Stichel D; Witt H; Ecker J; Wittmann A; Schittenhelm J; Ebinger M; Schuhmann MU; Figarella-Branger D; Aronica E; Staszewski O; Preusser M; Haberler C; Lauten M; Schüller U; Hartmann C; Snuderl M; Dunham C; Jabado N; Wesseling P; Deckert M; Keyvani K; Gottardo N; Giangaspero F; von Hoff K; Ellison DW; Pietsch T; Herold-Mende C; Milde T; Witt O; Kool M; Korshunov A; Wick W; von Deimling A; Pfister SM; Jones DTW; Sahm F
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):422-430. PubMed ID: 31867747
[TBL] [Abstract][Full Text] [Related]
36. Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
Tam OCH; Ho RSL; Chan S; Li KKW; Lam TL; Cheung ETY; Cheung OY; Ho WWS; Cheng KKF; Shing MMK; Ku DTL; Chung BHY; Yang W; Chan GCF; Ng HK; Liu APY
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835574
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.
Pratt D; Sahm F; Aldape K
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S16-S29. PubMed ID: 34725697
[TBL] [Abstract][Full Text] [Related]
38. DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profiles.
Safaei S; Mohme M; Niesen J; Schüller U; Bockmayr M
Oncoimmunology; 2021; 10(1):1932365. PubMed ID: 34235002
[TBL] [Abstract][Full Text] [Related]
39. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
[TBL] [Abstract][Full Text] [Related]
40. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
